Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In patients with type 2 diabetes, the RENAAL trial evaluated 1,513 participants with overt nephropathy (169)
Additional Information Good to Know Dermatologically tested for safety and efficacy
Beyond fat loss, Tesamorelin increases lean body mass by 1.42 kg across randomized clinical trials, improves lipid profiles (reducing triglycerides by 48 mg/dL and total cholesterol by 8 mg/dL at 52 weeks), and lowers hepatic fat fraction by 4.9% at 12 months in patients with NAFLD
Statistical analysis Data are represented as the means.e.m
US$ 27.85
US$ 22.10
US$ 22.17
US$ 20.10
US$ 28.26
